RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Greensboro, NC · Monroe, NC · Morehead City, NC · +56 more sites
Clinical trials in Monroe, NC
27 recruiting studies have a site in or near Monroe, NC, North Carolina.
Top conditions here
- Obesity (9)
- Hypertension (5)
- Breast Cancer (4)
- Type 2 Diabetes (3)
- Ulcerative Colitis (2)
- Prostate Cancer (2)
- Crohn's Disease (2)
- Heart Failure (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 27 of 27 studies
RecruitingPhase 3NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Charlotte, NC · Fuquay-Varina, NC · Monroe, NC · +92 more sites
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Durham, NC · Greenville, NC · High Point, NC · +270 more sites
RecruitingPhase 3NCT07845500
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Sponsor: Pfizer
Monroe, NC · Wilmington, NC · +14 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Albemarle, NC · Asheville, NC · Charlotte, NC · +331 more sites
RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Charlotte, NC · Durham, NC · Greensboro, NC · +137 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Greensboro, NC · Monroe, NC · Morehead City, NC · +37 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Greensboro, NC · Monroe, NC · Morehead City, NC · +77 more sites
RecruitingPhase 2NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Greensboro, NC · Monroe, NC · Morehead City, NC · +47 more sites
RecruitingPhase 3NCT07772921
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Sponsor: Pfizer
Monroe, NC · +6 more sites
RecruitingPhase 2NCT07142356
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Sponsor: Retension Pharmaceuticals. Inc.
Asheboro, NC · Charlotte, NC · Monroe, NC · +31 more sites
RecruitingPhase 2NCT06979336
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Sponsor: Genentech, Inc.
Monroe, NC · +7 more sites
RecruitingPhase 2NCT06343298
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Sponsor: E-Star BioTech, LLC
Monroe, NC · +22 more sites
RecruitingPhase 3NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Chapel Hill, NC · Charlotte, NC · Durham, NC · +122 more sites
RecruitingPhase 3NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Monroe, NC · +40 more sites
RecruitingPhase 3NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Sponsor: AstraZeneca
Greensboro, NC · Monroe, NC · +52 more sites
RecruitingPhase 3NCT06677060
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Sponsor: AstraZeneca
Charlotte, NC · Durham, NC · Fayetteville, NC · +195 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Albemarle, NC · Asheboro, NC · +1223 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Chapel Hill, NC · Charlotte, NC · Durham, NC · +115 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Albemarle, NC · Asheboro, NC · +825 more sites
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Albemarle, NC · Asheboro, NC · Burlington, NC · +378 more sites
RecruitingPhase 2NCT07543120
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Sponsor: Novartis Pharmaceuticals
Monroe, NC · +18 more sites
RecruitingPhase 2NCT07610278
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Sponsor: Novartis Pharmaceuticals
Monroe, NC · +28 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Charlotte, NC · +371 more sites
RecruitingPhase 3NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Sponsor: Eli Lilly and Company
Monroe, NC · +51 more sites
RecruitingPhase 2NCT07570758
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
Sponsor: ERX Pharmaceuticals
Monroe, NC · +2 more sites
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Albemarle, NC · Asheville, NC · +809 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.